Best treatment for small HER-2–positive, node-negative breast cancers unknown

Posted on March 3rd, 2010 by Beth Backus

HemOnc today
About 25% of breast cancers diagnosed in the United States are HER-2–positive. Research has established that the HER-2 phenotype is associated with poor DFS and OS.

Tags: Mayo Clinic Jacksonville

You must be logged-in to the site to post a comment.

Contact Us · Privacy Policy